Wells' syndrome and human immunodeficiency virus infection [22]

British Journal of Dermatology

Volumn 143, Issue 3, 2000, Pages 672-674

  Jones Caballero, M ^a,b   Perez Santos S ^a   Bermejo Martinez G ^c   Lecuna Echeverria M ^a   Lazaro Ochaita P ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b CEP Hermanos Sangro   (Spain)

^c Centro de Salud Federica Montseny   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; COTRIMOXAZOLE; DIDANOSINE; FOLIC ACID; METHADONE; NELFINAVIR; OPIATE; STAVUDINE;

ADULT; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; MALE; PRIORITY JOURNAL; URTICARIA; WELLS SYNDROME;

BIOPSY; CELLULITIS; EOSINOPHILIA; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; SYNDROME;

EID: 0033796078     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2000.03748.x     Document Type: Letter

References (17)

1. Wells' syndrome is a distinctive disease entity and not a histologic diagnosis
2. Interferon alfa treatment of a patient with eosinophilic cellulitis and HIV infection
3. A current perspective on the role of eosinophils in dermatologic diseases
4. Eosinophilic cellulitis
5. Low-dose alternate-day prednisone for persistent Wells' syndrome
6. Eosinophilic cellulitis associated with urticaria. A report of two cases
7. Wells' syndrome: Report of 2 cases
8. Recurrent vesiculobullous plaques. Eosinophilic cellulitis (Wells' syndrome)
9. Bulious delayed pressure urticaria; pressure testing may produce a systemic reaction
10. Delayed pressure urticaria. Clinical features, laboratory investigations, and response to therapy of 44 patients
11. Pressure urticaria - Histological study
12. Eosinophilic cellulitis - Persistent cutaneous swelling with phagocytosis of eosinophilic debris
13. Wells' syndrome
14. Wells' syndrome
15. Eosinophilic pustular folliculitis in patients with acquired immunodeficiency syndrome. Report of three cases
16. Eosinophilic cellulitis and eosinophilic pustular folliculitis
17. Cutaneous reactions at the site of post-infection gp160 vaccination therapy in HIV-1+ patients